Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This experimental toothpaste formulation, developed by GSK, is a multi-component topical dentifrice designed for the prevention of dental caries and the improvement of oral hygiene. It contains sodium fluoride (1150 ppm) as the primary anti-caries agent to promote enamel remineralization and inhibit demineralization. Phytate (inositol hexaphosphate) is included at concentrations up to 0.85% to provide enhanced extrinsic stain removal and prevention through calcium chelation. Zinc chloride (0.3%) is incorporated to inhibit oral malodour by neutralizing volatile sulfur compounds and providing antimicrobial activity. Sodium citrate (0.5%) serves as a buffering agent to maintain the formulation's stability and efficacy. The combination was evaluated in randomized, in situ clinical studies to ensure that the addition of phytate and zinc did not interfere with the fluoride-mediated remineralization process.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on phytate + zinc chloride + sodium citrate + sodium fluoride.